CD22 and COVID-19: BCR inhibitory gene expression was limited, but CD22 was detectable across B cell subsets in asymptomatic COVID-19, while FCGR2B, CD72 and PTPN6 expression was evident in B cells in severe COVID-19 (Fig. 4g and Extended Data Fig. 6e).